Information
1. microarray-based tests enable to evaluate risks for 14 male cancers and 15 female cancers.
2. With design best fitting Asian populations.
3. Combining assessments of genetic and environmental factors
4. Unique bialleleic probes to enhance the typing efficiency
Specification
Phalanx Biotech Group’s SNP ArrayPhalanx-Risk Evaluation genetic test for ObesityPhalanx-Risk Evaluation Genetic test for CancersPhalanx-Risk Evaluation genetic test for Chronic diseases
Benefits
Personalized genomic services are a scientific perspective to help you understand your genetic traits and provide the best response to disease prevention.
Clients
Medical institutions (hospitals, clinics), health management centers, weight management agencies, fitness centers, groups or individuals
